Impact of the Approval of Intravenous Recombinant Tissue Plasminogen Activator Therapy on the Processes of Acute Stroke Management in Japan-Reference-Cited by-同舟云学术

Impact of the Approval of Intravenous Recombinant Tissue Plasminogen Activator Therapy on the Processes of Acute Stroke Management in Japan

Published:2009-01 Issue:1 Volume:40 Page:30-34
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Sato Shoichiro¹,Uehara Toshiyuki¹,Toyoda Kazunori¹,Yasui Nobuyuki¹,Hata Takashi¹,Ueda Toshihiro¹,Okada Yasushi¹,Toyota Akihiro¹,Hasegawa Yasuhiro¹,Naritomi Hiroaki¹,Minematsu Kazuo¹,

Affiliation:

1. From Cerebrovascular Division (S.S., T. Uehara, K.T., H.N., K.M.), Department of Medicine, National Cardiovascular Center, Suita, Osaka, Japan; Department of Neurosurgery (N.Y.), Research Institute for Brain and Blood Vessels Akita, Akita, Japan; Department of Neurology (T.H., T. Ueda), Yokohama Stroke and Brain Center, Yokohama, Kanagawa, Japan; Rehabilitation Center (A.T.), Chugoku Rosai General Hospital, Kure, Hiroshima, Japan; Department of Cerebrovascular Disease (Y.O.), National Hospital...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference16 articles.

1. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

2. Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke

3. Tissue Plasminogen Activator for Acute Ischemic Stroke

4. Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset

5. Intravenous Thrombolysis in German Stroke Units before and after Regulatory Approval of Recombinant Tissue Plasminogen Activator

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rate of return to work in patients with stroke under the health and employment support program of Rosai hospitals in Japan;Scientific Reports;2023-09-22

2. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan;Journal of Stroke and Cerebrovascular Diseases;2019-11

3. Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke;Brain and Behavior;2017-12-07

4. Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan;Circulation Journal;2016

5. Comparison of the Time Course of Return to Work After Stroke Between Two Cohort Studies in Japan;Journal of UOEH;2016